Han Emilie, Gyöngyösi Mariann
Abteilung für Kardiologie, Universitätsklinik für Innere Medizin II, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090 Wien, Österreich.
J Gynakol Endokrinol. 2023;33(1):7-12. doi: 10.1007/s41974-023-00250-5. Epub 2023 Feb 2.
Long COVID (coronavirus disease) has been described as a new multi-organ disease, which appears to be more prevalent in women than in men. Pregnant and breastfeeding women are a special subgroup of patients to consider with long COVID, as only scarce data have been collected to date. Menstrual changes are commonly observed during or after COVID-19; some studies also attribute slight changes of cycle length to previous inoculation against the virus. Pregnant women who have a symptomatic infection with severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are at a higher risk for adverse outcomes and pregnancy-associated complications. Moreover, more and robust data are required to evaluate vertical transmission. COVID vaccines are the most effective tool against the pandemic, as they prevent infection, but also appear to be able to ease long COVID symptoms. Vaccines have been proven safe and effective in both pregnant and breastfeeding women. This article aims to present current data on long COVID in pregnant and breastfeeding women and elucidate risk factors and possible treatment options.
长期新冠（冠状病毒病）被描述为一种新的多器官疾病，女性似乎比男性更为普遍。孕妇和哺乳期妇女是需要考虑的长期新冠特殊患者亚组，因为迄今为止仅收集到稀缺的数据。月经变化在新冠疫情期间或之后很常见；一些研究还将周期长度的轻微变化归因于先前接种的新冠病毒疫苗。感染严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）且出现症状的孕妇出现不良结局和妊娠相关并发症的风险更高。此外，评估垂直传播需要更多有力的数据。新冠疫苗是应对这一疫情的最有效工具，因为它们可预防感染，而且似乎还能够缓解长期新冠症状。疫苗已在孕妇和哺乳期妇女中被证明是安全有效的。本文旨在介绍孕妇和哺乳期妇女长期新冠的当前数据，并阐明风险因素和可能的治疗选择。
